We’re moving on!
Join us at www.hcp.novartis.com—our new location for health care professionals to find product, access, and medical information. Now you can find the tools you need to help manage your patients, all in one place!
You’ll have access to the site in a moment, or click continue to close this message and advance directly to the site.
Clinical Development and Medical Affairs
Novartis is reimagining medicine through research and innovation.
Explore our resources for you and your patients.
AML = acute myeloid leukemia; MDS = myelodysplastic syndromes; CML = chronic myeloid leukemia; PROS = PIK3CA-related overgrowth spectrum.
